Antimicrobial susceptibility of major pathogens of orofacial odontogenic infections to 11 β-lactam antibiotics

Oral Microbiology and Immunology

Volumn 17, Issue 5, 2002, Pages 285-289

  Kuriyama, T ^a,b   Karasawa, T ^a   Nakagawa, K ^a   Nakamura, S ^a   Yamamoto, E ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

lactam antibiotics; Antimicrobial susceptibility; Orofacial odontogenic infections

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAM; CEFEPIME; CEFMETAZOLE; CEFOPERAZONE; CEFOSELIS; CEFPIROME; CEFTAZIDIME; CEFTIZOXIME; CEPHALOSPORIN DERIVATIVE; DRUG DERIVATIVE; FLOMOXEF; FROPENEM; IMIPENEM; LACTAM; PENICILLIN DERIVATIVE; PENICILLIN G; SULBACTAM;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; BACTERIUM; DRUG COMBINATION; DRUG EFFECT; FUSOBACTERIUM; HUMAN; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MOUTH DISEASE; PEPTOSTREPTOCOCCUS; PORPHYROMONAS GINGIVALIS; PREVOTELLA; STREPTOCOCCUS; STREPTOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; BACTEROIDACEAE INFECTIONS; BETA-LACTAMS; CEFMETAZOLE; CEFOPERAZONE; CEFTAZIDIME; CEFTIZOXIME; CEPHALOSPORINS; DRUG RESISTANCE, BACTERIAL; DRUG THERAPY, COMBINATION; FUSOBACTERIUM; FUSOBACTERIUM INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; IMIPENEM; LACTAMS; MICROBIAL SENSITIVITY TESTS; MOUTH DISEASES; PENICILLIN G; PENICILLINS; PEPTOSTREPTOCOCCUS; PORPHYROMONAS GINGIVALIS; PREVOTELLA; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS; SULBACTAM;

EID: 0036800848     PISSN: 09020055     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-302X.2002.170504.x     Document Type: Article

References (15)

1. Finegold SM. Therapy of anaerobic infections. In: Finegold SM, George WL, ed. Anaerobic infections in humans. London: Academic Press, 1989: 793 818.
2. Gill Y, Scully C. Orofacial odontogenic infections: review of microbiology and current treatment. Oral Surg Oral Med Oral Pathol 1990: 70: 155 158.
3. Kuriyama T, Karasawa T, Nakagawa K, Saiki Y, Yamamoto E, Nakamura S. Bacteriologic features and antimicrobial susceptibility in isolates from orofacial odontogenic infections. Oral Surg Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000: 90: 600 608.
4. Kuriyama T, Karasawa T, Nakagawa K, Yamamoto E, Nakamura S. Incidence of β-lactamase production and antimicrobial susceptibility of anaerobic gram-negative rods isolated from pus specimens of orofacial odontogenic infections. Oral Microbiol Immunol 2001: 16: 10 15.
5. Kuriyama T, Karasawa T, Nakagawa K, Yamamoto E, Nakamura S. Bacteriology and antimicrobial susceptibility of gram-positive cocci isolated from pus specimens of orofacial odontogenic infections. Oral Microbiol Immunol 2002: 17: 132 135.
6. Laskin DM, Laskin JL. Odontogenic infections of the head and neck. In: Lakin DM, ed. Oral and maxillofacial surgery. St. Louis: Mosby, 1985: 219 252.
7. Mandell GL, Petri WA Jr. Antimicrobial agents. Penicillins, cephalosporins, and other β-lactam antibiotics. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG, ed. Goodman and Gilman's the pharmacological basis of therapeutics, 9th edn. New York: McGraw-Hill Co., 1996: 1073 1101.
8. National Committee for Clinical Laboratory Standards. Methods for antimicrobial susceptibility testing of anaerobic bacteria. 4th edition. Approved standard. NCCLS document M11-A4, Villanova: National Committee for Clinical Laboratory Standards, 1997.
9. National Committee for Clinical Laboratory Standards. Methods for antimicrobial susceptibility tests for bacteria that grow aerobically. 4th edition. Approved standard NCCLS document M7-A4. Villanova: National Committee for Clinical Laboratory Standard, 1998.
10. Peterson LJ. Principles of management and prevention of odontogenic infections. In: Peterson LJ, Ellis III E, Hupp JR, Tucker MR, ed. Contemporary Oral and Maxillofacial Surgery. St. Louis: Mosby, 1998: 392 417.
11. Ruckdeschel G, Eder W. Comparative in vitro activity of the new oxacephem antibiotic, flomoxef (6315-S). Eur J Clin Microbiol Infect Dis 1988: 7: 687 691.
12. Sandor GK, Low DE, Judd PL, Davidson RJ. Antimicrobial treatment options in the management of odontogenic infections. J Can Dent Assoc 1998: 64: 508 514.
13. Spangler SK, Jacobs MR, Appelbaum PC. Activity of WY-49605 compared with those of amoxicillin, amoxicillin-clavulanate, imipenem, ciprofloxacin, cefaclor, cefpodoxime, cefuroxime, clindamycin, and metronidazole against 384 anaerobic bacteria. Antimicrob Agents Chemother 1994: 38: 2599 2604.
14. Wexler HM, Finegold SM. In vitro activity of imipenem against anaerobic bacteria. Rev Infect Dis 1985: 7 (Suppl. 3): S417 S425.
15. Wexler HM, Molitoris E, Finegold SM. Effect of β-lactamase inhibitors on the activities of various β-lactam agents against anaerobic bacteria. Antimicrob Agents Chemother 1991: 35: 1219 1224.